ArticleHaematologica2026
Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centers.
Peter May et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it